DURECT Corporation (DRRX)
NASDAQ: DRRX · IEX Real-Time Price · USD
1.603
+0.013 (0.82%)
Jul 22, 2024, 9:59 AM EDT - Market open
DURECT Employees
DURECT had 58 employees as of December 31, 2023. The number of employees decreased by 21 or -26.58% compared to the previous year.
Employees
58
Change (1Y)
-21
Growth (1Y)
-26.58%
Revenue / Employee
$143,466
Profits / Employee
-$401,379
Market Cap
47.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Inotiv | 2,055 |
Bionano Genomics | 344 |
NextCure | 82 |
Aerovate Therapeutics | 51 |
Modular Medical | 40 |
Lantern Pharma | 21 |
vTv Therapeutics | 16 |
Reneo Pharmaceuticals | 8 |
DRRX News
- 2 months ago - DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis - PRNewsWire
- 2 months ago - DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update - PRNewsWire
- 2 months ago - DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update - PRNewsWire
- 2 months ago - DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis - PRNewsWire
- 4 months ago - DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - PRNewsWire
- 4 months ago - DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update - PRNewsWire
- 5 months ago - DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada - PRNewsWire
- 5 months ago - DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference - PRNewsWire